Global Pharmaceutical News

Bristol Myers stumbles in bid to widen heart drug’s use

Inside the market of emerging biotech

US CDC advisers begin review of vaccine guidelines after months-long delay

GSK in breach for misleading prescription information on Omjjara, industry body says

China's Duality Biotherapeutics shares rise more than double in Hong Kong debut

UK's Haleon takes full control of Chinese consumer healthcare venture

US steps up probes into pharmaceutical, chip imports, setting stage for tariffs

Tariff wars to hit popular US-made drugs in China, regulator data shows

MIT researchers repurpose cancer compound to treat PKD I QUANTUNG PHARMA I www.quantung.com

Synendos receives EMA nod for brain therapy I QUANTUNG PHARMA I www.quantung.com

Serac to present data from DETECT study I QUANTUNG PHARMA I www.quantung.com

StemSight and ERS Genomics focus on collaboration I QUANTUNG PHARMA I www.quantung.com

Virtual reality training to help NHS doctors spot signs of sepsis I QUANTUNG PHARMA I www.quantung.com

Poolbeg’s cytokine release syndrome drug shows potential I QUANTUNG PHARMA I www.quantung.com

NHS to test new blood group genotyping test on inherited blood disorder patients

Exclusive: Suspected fake Ozempic linked to three US cases of hypoglycemia

The FDA has approved the therapy based on data from the Phase III PROPEL pivotal study.

The latest development is based on data from Phase III ADVANCE and PROGRESS clinical trials.

Fabre-Kramer gains FDA approval for major depressive disorder therapy – www.quantung.com – Quantung Pharmaceutical export

Biomass will be used to meet particularly high energy demands, according to the German government's so-called "Easter Package", which aims t